1.20 USD
+0.02
1.69%
At close Jan 17, 4:00 PM EST
Pre-market
1.20
+0.00
0.00%
1 day
1.69%
5 days
0.00%
1 month
-3.23%
3 months
-23.57%
6 months
-36.84%
Year to date
-17.81%
1 year
-41.75%
5 years
-94.28%
10 years
-94.64%
 

About: Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure consists of CBD products and alcohol.

Employees: 2,650

0
Funds holding %
of 6,823 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

12% more capital invested

Capital invested by funds: $145M [Q2] → $162M (+$17M) [Q3]

5% more repeat investments, than reductions

Existing positions increased: 91 | Existing positions reduced: 87

0.06% less ownership

Funds ownership: 10.55% [Q2] → 10.49% (-0.06%) [Q3]

5% less first-time investments, than exits

New positions opened: 35 | Existing positions closed: 37

2% less funds holding

Funds holding: 353 [Q2] → 345 (-8) [Q3]

10% less call options, than puts

Call options by funds: $21.2M | Put options by funds: $23.6M

100% less funds holding in top 10

Funds holding in top 10: 1 [Q2] → 0 (-1) [Q3]

Research analyst outlook

We haven’t received any recent analyst ratings for TLRY.

Financial journalist opinion

Based on 24 articles about TLRY published over the past 30 days

Positive
MarijuanaStocks
3 days ago
Canadian Marijuana Stocks To Watch To Close Out The Week
Marijuana stock investing in 2025 may be easier than you think. With a new year just getting started volatility could change to upward momentum. As 2025 is underway the chances to vote on bills and change the cannabis industry are upon us in the USA. In addition to other global regions looking to enter the space. What initially makes it easier is currently the sector is currently trading at low entry points.
Canadian Marijuana Stocks To Watch To Close Out The Week
Negative
The Motley Fool
6 days ago
Why Tilray Stock Plummeted by 42% in 2024
Any investor hoping to reap the rewards by holding marijuana companies must be a shiny-eyed optimist at this point. Weed companies are among the worst performers on the stock exchange since they are constantly barraged by headwinds in North America.
Why Tilray Stock Plummeted by 42% in 2024
Negative
Seeking Alpha
6 days ago
Tilray: Back To Square One (Rating Downgrade)
Tilray shares fell over 10% after another revenue miss and significant cash burn, raising concerns about the stock setting new lows. Despite some growth in beverage revenues, overall financials remain bleak, with continued losses and significant shareholder dilution. If cash burn doesn't improve, investors will be significantly diluted even more, potentially leading to a reverse split if the stock falls below $1.
Tilray: Back To Square One (Rating Downgrade)
Negative
Proactive Investors
1 week ago
Tilray Brands shares fall on quarterly revenue miss
Tilray Brands (NASDAQ:TLRY) shares plunged more than 11% following the release of its fiscal second quarter 2025 earnings report, where sales fell short of estimates.   The company reported net revenue of $211 million for the quarter, marking a 9% increase year-over-year but falling short of analysts' expectations of $216.3 million.
Tilray Brands shares fall on quarterly revenue miss
Neutral
Seeking Alpha
1 week ago
Tilray Brands, Inc. (TLRY) Q2 2025 Earnings Call Transcript
Tilray Brands, Inc. (NASDAQ:TLRY ) Q2 2025 Earnings Conference Call January 10, 2025 8:30 AM ET Company Participants Berrin Noorata - Chief Corporate Affairs & Communications Officer Irwin Simon - Chairman & Chief Executive Officer Carl Merton - Chief Financial Officer Ty Gilmore - President, Tilray Beverages North America Blair MacNeil - President, Tilray Canada Denise Faltischek - Chief Strategy Officer & Head, International Conference Call Participants Kaumil Gajrawala - Jefferies Robert Moskow - TD Cowen Aaron Grey - Alliance Global Partners Frederico Gomes - ATB Capital Markets Bill Kirk - Roth MKM Matt Bottomley - Canaccord Genuity Pablo Zuanic - Zuanic & Associates Michael Lavery - Piper Sandler Operator Thank you for joining us for today's conference call to discuss Tilray Brands' Financial Results for the Second Quarter ended November 30, 2024. All lines have been placed on mute to prevent any background noise.
Tilray Brands, Inc. (TLRY) Q2 2025 Earnings Call Transcript
Negative
The Motley Fool
1 week ago
Why Tilray Brands Stock Crashed 12% on Friday
Tilray Brands (TLRY -11.56%) stock tumbled 12% through 9:50 a.m. ET after missing analyst sales forecasts in its Friday morning report.
Why Tilray Brands Stock Crashed 12% on Friday
Neutral
Zacks Investment Research
1 week ago
Tilray Brands (TLRY) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
While the top- and bottom-line numbers for Tilray Brands (TLRY) give a sense of how the business performed in the quarter ended November 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Tilray Brands (TLRY) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Neutral
Benzinga
1 week ago
Cannabis/Beer Company Tilray Outlines Plan To Reduce Its Beverage Portfolio, Reports Mixed Q2 Earnings
On Friday, Tilray Brands, Inc's. TLRY second-quarter net revenue increased 9% year-over-year to $210.95 million, missing the consensus of $216.91 million.
Cannabis/Beer Company Tilray Outlines Plan To Reduce Its Beverage Portfolio, Reports Mixed Q2 Earnings
Negative
Zacks Investment Research
1 week ago
Tilray Brands, Inc. (TLRY) Reports Q2 Loss, Misses Revenue Estimates
Tilray Brands, Inc. (TLRY) came out with a quarterly loss of $0.10 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to break-even earnings per share a year ago.
Tilray Brands, Inc. (TLRY) Reports Q2 Loss, Misses Revenue Estimates
Negative
Market Watch
1 week ago
Tilray's stock slumps as cannabis and beer maker plans to cut its drinks lineup
The beer and cannabis company's revenue fell short of analyst estimates.
Tilray's stock slumps as cannabis and beer maker plans to cut its drinks lineup
Charts implemented using Lightweight Charts™